Montana AG sues Janssen, AstraZeneca
Pharma Compliance Alert, February 27, 2008
Montana Attorney General Mike McGrath became the latest to file suit against Janssen and AstraZeneca over the atypical anti-psychotics Risperdol and Seroquel.
In the suit McGrath claims the drugs were "in defective condition and unreasonably dangerous."
The suit contends the companies failed to warn physicians and consumers about the dangers of the two drugs. The AG said the companies engaged in false and misleading marketing, advertising, and sales campaigns promoting off-label uses of the drugs.
McGrath seeks civil penalties of $10,000 for each violation of state law, an order returning to the state all revenues made by the two companies here for sales of the drugs to Montanans, restitution, triple damages, and attorney fees. McGrath also asked the court to award punitive and exemplary damages as appropriate.
Lawsuits have been filed against both companies in Arkansas, Pennsylvania, and South Carolina, while Janssen faces an additional suit in Louisiana.
Comments
0 comments on “Montana AG sues Janssen, AstraZeneca ”
Related Products
-
ePharm5 InDepth
EPharm5 e-mail newsletter delivers the top 5 developments in pharma business innovation, with original research, interviews...
-
Big Pharma Performance Before, During and Beyond the Global Recession
This report assesses the performance of the leading 15 pharmaceutical companies up to, during and beyond the recent global...
Most Popular
- Articles
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- Topic: CMS, OESS post new security compliance review information, checklist
- What does case-mix index mean to you?
- QA:Coding multiple initial infusions
- Capturing all necessary codes for IUD insertion and removal can be challenging
- News and briefs: Oklahoma Osteopathic Association against residency bill change
- OB services: Coding inside and outside of the package
- HIPAA Q&A: Level of encryption needed for email
- E-mailed
-
- Q/A: Volume requirement for reporting hydration services
- Featured blog post: Nurses face felony charges after reporting physician to the Texas Medical Board
- Catch up on what's new with injections and infusions
- New conflicts of interest create new challenges
- What does case-mix index mean to you?
- Joint Commission Center announces handoff communication solutions
- Inside best practice: Reduce patient falls with a stoplight
- Identify modifiable risk factors to prevent patient falls
- Hospitalist-surgeon comanagement has no effect on outcomes
- HIPAA Q&A: Level of encryption needed for email
- Searched